Phosphorylated tau (p-tau), a hallmark biomarker in Alzheimer’s, does not typically show a specific elevation in MS except in cases where an MS patient has coexisting Alzheimer pathology. The gene discussed is MAPT; the disease is myeloid sarcoma.